Table 3.
Incidence and prevalence of hypoglycemic episodes during the 3-d glucose monitoring period after RYGB surgery
| Animal ID | Onset of hypoglycemia (no. of days after surgery) | No. of episodes of hypoglycemia |
| Dosed treatment group | ||
| 7 | 1 | 4 |
| 1 | 2 | 2 |
| 9 | 2 | 2 |
| 12 | 2 | 2 |
| 14 | 2 | 2 |
| 5 | 1 | 1 |
| 6 | 1 | 1 |
| Total | 14 | |
| No-dose treatment group | ||
| 8 | 1 | 7 |
| 10 | 1 | 3 |
| 15 | 2 | 3 |
| 2 | 2 | 2 |
| 3 | 2 | 2 |
| 11 | 1 | 2 |
| 13 | 2 | 1 |
| Total | 20 | |
| Not enrolleda | ||
| 4 | not applicable | not applicable |
| 16 | not applicable | not applicable |
a
Animals that failed to reach the hypoglycemia threshold (60 mg/dL) during the 3-d examination period were not enrolled in either treatment group.